Anus disorder
MONDO:0002519A non-neoplastic or neoplastic disorder that affects the anal canal or anal margin. Representative examples of non-neoplastic disorders include hemorrhoids and anal ulcer. Representative examples of neoplastic disorders include carcinoma, lymphoma, and melanoma.
Also known as: anal disorder, anus disease, anus disease or disorder, disease of anus, disease or disorder of anus, disorder of anal region, disorder of anus, Ulcer of anus
173 clinical trials for this condition and its sub-types, 3 tagged with Anus disorder itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Anus disorder
-
Anus neoplasm 87 trials · 140 incl. sub-types
3 sub-types
- Anus cancer 4 trials · 133 incl. sub-types Sub-types →
- Anal gland neoplasm 0 trials
- Benign neoplasm of anus 0 trials Sub-types →
-
Proctitis 2 trials · 21 incl. sub-types
2 sub-types
- Radiation proctitis 13 trials
- Proctocolitis 2 trials · 7 incl. sub-types Sub-types →
-
Imperforate anus 6 trials
-
Levator syndrome 1 trial
-
Anal polyp 0 trials
1 sub-type
- Fibroepithelial polyp of the anus 0 trials
-
Anal spasm 0 trials
-
Anorectal stricture 0 trials
Most studied deeper sub-types
-
New drug combo targets Hard-to-Treat cancers
Disease control Stopped earlyThis early-phase study tests an experimental drug called INCB177054, given alone or with another drug (retifanlimab), in people with advanced or metastatic solid tumors that have not responded to standard treatments. The main goals are to check safety and find the right dose. Abo…
Phase 1/2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Experimental cancer combo shows early promise but study halted
Disease control Stopped earlyThis early-phase trial tested a new drug called nanrilkefusp alfa, which helps activate immune cells, both alone and combined with the immunotherapy pembrolizumab. It included 115 people with various advanced solid tumors that had stopped responding to standard treatments. The st…
Phase 1 • Sponsor: SOTIO Biotech AG • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Experimental drug targets Hard-to-Treat cancers, but trial ends early
Disease control Stopped earlyThis study tested an experimental drug called vobramitamab duocarmazine in people with advanced prostate cancer and other solid tumors that stopped responding to standard treatments. The goal was to see if the drug could shrink tumors or slow cancer growth. The trial was terminat…
Phase 2 • Sponsor: MacroGenics • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
HIV cancer hope: immune combo shows early promise but trial halted
Disease control Stopped earlyThis early-phase trial tested two immunotherapy drugs, ipilimumab and nivolumab, in people with HIV who had advanced solid tumors or Hodgkin lymphoma that had spread or come back. The goal was to find the safest dose and see if the combination could shrink tumors. The study was t…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Battle of the scalpels: which surgery is best for early rectal cancer?
Disease control Stopped earlyThis study compared two procedures for removing early-stage rectal cancer or precancerous growths: endoscopic submucosal dissection (ESD) and transanal endoscopic microsurgery (TEM). Both are less invasive than traditional surgery. The goal was to see which one removes the tumor …
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Experimental cancer drug trial ends early
Disease control Stopped earlyThis early-stage study tested an experimental drug called INCB099318 in people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety and how the body processes it. The study was terminated early, so results are…
Phase 1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug combo tested for Hard-to-Treat cancers
Disease control Stopped earlyThis early-phase trial tested an experimental drug called INCA00186, alone or with other immunotherapy drugs, in people with advanced solid tumors such as head and neck or gastrointestinal cancers. The study aimed to find safe doses and check for early signs of effectiveness. It …
Phase 1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 26, 2026 12:43 UTC
-
Skin-Saving paste for cancer radiation falls short in tiny trial
Prevention Stopped earlyThis study tested whether Alkagin paste could prevent skin damage in patients receiving radiation for anal, rectal, or gynecological cancers. Only 2 people enrolled before the trial was stopped early. Because of this, we cannot draw any reliable conclusions about the paste's effe…
Phase 2 • Sponsor: Sir Mortimer B. Davis - Jewish General Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
New bundled care approach aims to ease chronic pelvic pain
Symptom relief Stopped earlyThis study looked at whether a combined treatment plan—including physical therapy, behavioral health therapy, and medical procedures—could reduce symptoms of chronic bladder pain. Researchers compared this bundled approach to usual care in 26 women with interstitial cystitis or b…
Phase 3 • Sponsor: Jocelyn Fitzgerald • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC